CÁTEDRA DE INVESTIGACIÓN
Contract CATEDRA2014-009
Medicamentos biotecnológicos: de la biología molecular a las terapias humanas- AMGEN
Funder:
AMGEN, S.A.
date_range
Duration: from 05 December 2014 to 01 March 2016
(15 months)
Of National scope. It has been granted under a regime of Direct grant.
Researchers
Lucinda
Villaescusa Castillo
Leader